Milos Miljkovic

Milos Miljkovic discloses dealings in Cartesian Therapeutics, Inc. to SEC (Form 4). Over a trading history stretching from 2 January 2024 to 6 January 2026, the count stands at 6 filings.

Sales make up the whole of the open-market record (2 sales, €36k). Other entries cover 3 share grants and 1 option exercise. In 2026 alone, the filings show no purchases and 1 sale.

Most recently, on 8 January 2026, the filings show an open-market sale worth €21k in Cartesian Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.